Chemed Corporation (NYSE:CHE) Short Interest Update

Chemed Corporation (NYSE:CHE) saw a large decline in short interest in February. As of February 27th, there was short interest totaling 459,863 shares, a decline of 20.0% from the February 12th total of 575,139 shares. Approximately 3.5% of the company’s shares are short sold. Based on an average trading volume of 267,665 shares, the days-to-cover ratio is presently 1.7 days. Based on an average trading volume of 267,665 shares, the days-to-cover ratio is presently 1.7 days. Approximately 3.5% of the company’s shares are short sold.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the transaction, the chief executive officer owned 93,719 shares in the company, valued at $37,785,626.42. The trade was a 2.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 3.29% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Monetary Solutions Ltd purchased a new stake in Chemed in the 4th quarter valued at $25,000. Los Angeles Capital Management LLC purchased a new position in Chemed during the 4th quarter worth $26,000. Smartleaf Asset Management LLC grew its stake in shares of Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. bought a new stake in shares of Chemed in the 4th quarter worth $27,000. Finally, First Horizon Corp purchased a new stake in shares of Chemed in the third quarter valued at about $31,000. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Up 0.2%

CHE traded up $0.96 during trading on Tuesday, hitting $399.29. 256,972 shares of the company’s stock were exchanged, compared to its average volume of 209,184. Chemed has a fifty-two week low of $385.00 and a fifty-two week high of $623.60. The stock has a market cap of $5.50 billion, a P/E ratio of 21.74, a PEG ratio of 1.59 and a beta of 0.47. The business’s 50 day moving average is $440.69 and its two-hundred day moving average is $440.44.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The business had revenue of $639.34 million for the quarter, compared to analyst estimates of $659.09 million. During the same quarter in the prior year, the business earned $6.83 earnings per share. The firm’s quarterly revenue was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, sell-side analysts forecast that Chemed will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s payout ratio is currently 13.06%.

Analyst Ratings Changes

CHE has been the subject of several research analyst reports. Oppenheimer decreased their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Zacks Research lowered Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $422.00 price target (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $498.00.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.